Insulet Corporation V. Eoflow, Co. Ltd. Et Al

Case Background

On August 3, 2023, Plaintiff Insulet Corporation filed a patent infringement lawsuit and trade secret misappropriation in the United States District Court, District of Massachusetts (Case number: 1:23cv11780). This case was assigned to Chief Judge F. Dennis Saylor, IV, and referred to Magistrate Judge Jessica D. Hedges.

Cause

Insulet Corporation, a pioneer in diabetes management, developed the Omnipod System—a first-of-its-kind adhesive, wearable, and disposable insulin patch pump. This breakthrough eliminated the need for bulky insulin delivery systems. After years of investment exceeding $600 million in research, development, and manufacturing innovations, Insulet’s Omnipod evolved through several generations, culminating in the Omnipod DASH and Omnipod 5. Defendants EOFlow Co., Ltd., EOFlow Inc., and Flextronics (including affiliates Flex MSM and Flex US), alongside former Insulet employees Luis J. Malave, Steven DiIanni, and Ian G. Welsford, allegedly misappropriated Insulet's proprietary information. EOFlow, initially unable to produce a viable insulin patch pump, restructured its development strategy in 2016 after hiring former Insulet executives and entering a partnership with Flex, Insulet’s sole manufacturer. Subsequently, EOFlow developed the EOPatch—an insulin patch pump that is allegedly strikingly similar to Insulet's Omnipod in both design and function.

Injuries

Insulet suffered significant harm due to EOFlow’s actions, including the unauthorized use of its trade secret and inte